Taxis Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Taxis Pharmaceuticals

Access the complete profile.

Taxis Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	9 Deerpark Dr Ste J15 Monmouth Junction, NJ 08852

Note: Revenues for privately held companies are statistical evaluations.


Taxis Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Taxis Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Taxis Pharmaceuticals is classified as operating in the Legal Services industry, NAICS Code 5411.

Taxis Pharmaceuticals Annual Revenue and Growth Rate

Taxis Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Taxis Pharmaceuticals's revenues are gauged from an analysis of company filings.

Taxis Pharmaceuticals's Income Statement (based on Industry Averages)

Taxis Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Taxis Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 10, 2019	7	23%	$5 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Taxis Pharmaceuticals is developing and marketing. Taxis Pharmaceuticals doesn't have any recent trademark applications, indicating Taxis Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TAXISTANCE Anti-infectives	07/25/2017

See all trademarks and details in the Full Report.

Market Share of Taxis Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Taxis Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Taxis Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NORRIS MCLAUGHLIN P.A.	Bridgewater, NJ	100
GREENBAUM ROWE SMITH & DAVIS	Iselin, NJ	40
METHFESSEL & WERBEL P.C.	Edison, NJ	32
LEVINSON AXELROD P.A.	Edison, NJ	27
GOLDEN ROTHSCHILD SPAGNOLA LUNDELL BOYLAN GARUBO & BELL P.C.	Bridgewater, NJ	17
RAINONE COUGHLIN MINCHELLO	Iselin, NJ	16

Future Competition: Taxis Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Taxis Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)